It’s the second time this year I’ve purchased it.
This is a high-quality company that has positioned itself very well to take advantage of a number of major trends in healthcare. Excellent fundamentals, a 3%+ yield, a moderate payout ratio, almost a decade of dividend raises, double-digit long-term dividend growth, and the potential that shares are 26% undervalued are all reasons why dividend growth investors should take a strong look at this stock.
This company runs a very simple business model that provides a necessary and ubiquitous service to millions of people. With a 5%+ yield, a reasonable payout ratio, almost 20 consecutive years of dividend raises, and the potential that shares are 9% undervalued, this is a rare high-yield dividend growth stock that looks undervalued in today’s market.